Literature DB >> 11786962

Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma.

Toshiaki Ninomiya1, Koichiro Mihara, Kazuo Fushimi, Yoshitake Hayashi, Tomoko Hashimoto-Tamaoki, Taiki Tamaoki.   

Abstract

We investigated mechanisms regulating expression of alpha-fetoprotein (AFP) in 3 human hepatoma cell lines, HuH-7, HepG2, and huH-1, producing high, medium, and low levels of AFP, respectively. The silencer, a negative cis-acting element of the AFP gene, was highly activated in huH-1 and HepG2 to repress AFP enhancer activity by 91%, whereas only 26% repression was observed in HuH-7. To account for the difference in AFP production between HepG2 and huH-1, we investigated the roles of two isoforms of the AT motif-binding factor 1 (ATBF1) transcription factor, ATBF1-A and -B. Cotransfection assays showed that the ATBF1 isoforms regulated the AFP gene differently in HepG2 and huH-1. In huH-1 and HuH-7, both ATBF1 isoforms suppressed strongly enhancer activity and slightly promoter activity. In HepG2, on the other hand, ATBF1-A suppressed the enhancer and promoter activities, but surprisingly, ATBF1-B was found to stimulate enhancer activity while showing no effect on the promoter. Levels of ATBF1-A mRNA were similar in all 3 cell lines, whereas the expression ATBF1-B mRNA varied greatly, with the highest level seen in HepG2 followed by huH-1 and HuH-7. These results suggest that, in HepG2, ATBF1-B may have a dominant negative effect to relieve the transcriptional repression caused by its isoform. In support of this view, we found that the N-terminal region specific to the ATBF1-A molecule possessed transcriptional repressor activity. Thus, the use of the ATBF1 variants as well as the silencer may provide a unique mechanism that contributes to the determination of AFP levels in human hepatoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786962     DOI: 10.1053/jhep.2002.30420

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.

Authors:  Changying Fu; Na An; Jinming Liu; Jun A; Baotong Zhang; Mingcheng Liu; Zhiqian Zhang; Liya Fu; Xinxin Tian; Dan Wang; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2020-04-10       Impact factor: 5.157

2.  Nomogram model characterized by mutant genes and clinical indexes to identify high-risk patients with stage III/IV colorectal cancer.

Authors:  Kai Liu; Cui Wang; Jiefu Wang; Yang Zhan; Xin Yue; Dalu Kong
Journal:  J Gastrointest Oncol       Date:  2020-12

3.  Expression and subcellular localization of AT motif binding factor 1 in colon tumours.

Authors:  Hiromi Kataoka; Yutaka Miura; Makoto Kawaguchi; Shugo Suzuki; Yasuyuki Okamoto; Keiji Ozeki; Takaya Shimura; Tsutomu Mizoshita; Eiji Kubota; Satoshi Tanida; Satoru Takahashi; Kiyofumi Asai; Takashi Joh
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

4.  Novel Nucleotide Variations, Haplotypes Structure and Associations with Growth Related Traits of Goat AT Motif-Binding Factor (ATBF1) Gene.

Authors:  Xiaoyan Zhang; Xianfeng Wu; Wenchao Jia; Chuanying Pan; Xiangcheng Li; Chuzhao Lei; Hong Chen; Xianyong Lan
Journal:  Asian-Australas J Anim Sci       Date:  2015-10       Impact factor: 2.509

5.  TGF- β Signaling Cooperates with AT Motif-Binding Factor-1 for Repression of the α -Fetoprotein Promoter.

Authors:  Nobuo Sakata; Satoshi Kaneko; Souichi Ikeno; Yutaka Miura; Hidekazu Nakabayashi; Xue-Yuan Dong; Jin-Tang Dong; Taiki Tamaoki; Naoko Nakano; Susumu Itoh
Journal:  J Signal Transduct       Date:  2014-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.